BRPI1008213A2 - composições efervecentes e/ou solúveis por via oral contendo pelo menos um sal de s-adenosil metionina(same) - Google Patents
composições efervecentes e/ou solúveis por via oral contendo pelo menos um sal de s-adenosil metionina(same)Info
- Publication number
- BRPI1008213A2 BRPI1008213A2 BRPI1008213A BRPI1008213A BRPI1008213A2 BR PI1008213 A2 BRPI1008213 A2 BR PI1008213A2 BR PI1008213 A BRPI1008213 A BR PI1008213A BR PI1008213 A BRPI1008213 A BR PI1008213A BR PI1008213 A2 BRPI1008213 A2 BR PI1008213A2
- Authority
- BR
- Brazil
- Prior art keywords
- effervescent
- same
- compositions containing
- adenosyl methionine
- soluble compositions
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0007—Effervescent
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Nutrition Science (AREA)
- Molecular Biology (AREA)
- Physiology (AREA)
- Inorganic Chemistry (AREA)
- Zoology (AREA)
- Biophysics (AREA)
- Physical Education & Sports Medicine (AREA)
- Psychiatry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Gastroenterology & Hepatology (AREA)
- Hospice & Palliative Care (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Child & Adolescent Psychology (AREA)
- Pain & Pain Management (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ITMI2009A000162A IT1393331B1 (it) | 2009-02-09 | 2009-02-09 | Composizioni orosolubili e/o effervescenti contenenti almeno un sale di s-adenosilmetionina (same) |
| US21955309P | 2009-06-23 | 2009-06-23 | |
| PCT/IB2010/050087 WO2010089674A1 (en) | 2009-02-09 | 2010-01-11 | Orosoluble and/or effervescent compositions containing at least a salt of s- adenosyl methionine (same) |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BRPI1008213A2 true BRPI1008213A2 (pt) | 2016-03-15 |
Family
ID=40995758
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI1008213A BRPI1008213A2 (pt) | 2009-02-09 | 2010-01-11 | composições efervecentes e/ou solúveis por via oral contendo pelo menos um sal de s-adenosil metionina(same) |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US10149821B2 (pt) |
| EP (1) | EP2393475B1 (pt) |
| AU (1) | AU2010212042A1 (pt) |
| BR (1) | BRPI1008213A2 (pt) |
| CA (1) | CA2752009C (pt) |
| DK (1) | DK2393475T3 (pt) |
| ES (1) | ES2539310T3 (pt) |
| IL (1) | IL213817A0 (pt) |
| IT (1) | IT1393331B1 (pt) |
| PL (1) | PL2393475T3 (pt) |
| PT (1) | PT2393475E (pt) |
| RU (1) | RU2524645C2 (pt) |
| WO (1) | WO2010089674A1 (pt) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2963239B1 (fr) * | 2010-08-02 | 2013-03-08 | Vetalis | Formes galeniques effervescentes solides pour animaux |
| CN103841977B (zh) | 2011-08-12 | 2016-04-20 | 三菱瓦斯化学株式会社 | 保存稳定性优异的含s-腺苷-l-蛋氨酸的组合物 |
| US8877259B2 (en) | 2012-02-09 | 2014-11-04 | Mary Kay Inc. | Cosmetic formulation |
| CN104418928B (zh) * | 2013-08-27 | 2017-03-29 | 上海医药工业研究院 | 一种1,4‑丁二磺酸腺苷蛋氨酸的制备方法 |
| US9351921B1 (en) * | 2013-09-10 | 2016-05-31 | Spa De Soleil, Inc. | Microdermabrasion cream |
| AT14825U1 (de) * | 2014-11-10 | 2016-07-15 | Eduard Rappold | Kombinationspräparat enthaltend Ademetionin und Vitamin B12 zur Behandlung und Prävention der Alzheimer-Krankheit Typ I (LOAD) |
| ES2586632B1 (es) * | 2015-01-29 | 2017-09-05 | Wug Functional Gums, S.L | Composición para elaborar chicles |
| US9446100B2 (en) | 2015-02-13 | 2016-09-20 | Eastern Vision Limited | Dietary supplements and formulations |
| CN104983026A (zh) * | 2015-07-21 | 2015-10-21 | 上海海洋大学 | 山楂泡腾片及其制备方法 |
| WO2017040611A1 (en) * | 2015-08-31 | 2017-03-09 | Nutramax Laboratories, Inc. | Compositions comprising magnolia, phellodendron, theanine and/or whey protein |
| RU2611411C1 (ru) * | 2016-01-11 | 2017-02-21 | Общество с ограниченной ответственностью "Трейдсервис" | Диспергируемая в воде таблетка ацетилцистеина и способ ее изготовления |
| ITUA20163269A1 (it) | 2016-05-09 | 2017-11-09 | Graal S R L | Composizione ad assorbimento orobuccale per la neuro-protezione |
| IT201600080839A1 (it) * | 2016-08-01 | 2018-02-01 | Esserre Pharma Srl | Composizione a base di S-Adenosil-L-Metionina e Melatonina per il trattamento dei disturbi del comportamento alimentare |
| US10881686B2 (en) * | 2017-10-27 | 2021-01-05 | Zeta Biolongevity, Inc | Compositions and methods for treating and preventing proteinuria and endothelial erosion |
| IT201900015192A1 (it) | 2019-08-29 | 2021-03-01 | Graal S R L | Formulazioni edibili a base di principi attivi e arginina |
| CN111172043B (zh) * | 2020-01-14 | 2021-03-05 | 北京工商大学 | 一种提高紫红曲霉中红曲色素合成的发酵方法 |
| IT202000006127A1 (it) * | 2020-03-23 | 2021-09-23 | Fmc S R L | Formulazione farmaceutica, dietetica e/o alimentare a base ademetionina e processo di realizzazione di detta formulazione |
| CN111297963B (zh) * | 2020-04-10 | 2021-11-26 | 广东轻工职业技术学院 | 一种解酒护肝提取物、组合物及制备方法与应用 |
| IT202000008482A1 (it) * | 2020-04-21 | 2021-10-21 | Montefarmaco Otc S P A | Composizione orale contente s-adenosil metionina (same) e almeno un probiotico e suo uso |
| RU2749833C1 (ru) * | 2020-08-11 | 2021-06-17 | Федеральное государственное бюджетное образовательное учреждение высшего образования "Московский государственный университет технологий и управления имени К.Г. Разумовского (ПКУ)" | Способ производства диетического витаминизированного шоколада |
| IT202000030914A1 (it) * | 2020-12-15 | 2022-06-15 | Mario Antonio Basile | Composizione farmaceutica solida di ademetionina e cannabidiolo e procedimento per ottenerla |
| WO2024149826A1 (en) * | 2023-01-12 | 2024-07-18 | Institut National de la Santé et de la Recherche Médicale | New pharmaceutical methionine formulation |
| WO2023228167A2 (en) * | 2023-09-04 | 2023-11-30 | Carlo De Angelis | Solid food or pharmaceutical formulation, methods for obtaining and drying it and its uses in pharmaceutical, nutraceutical or veterinary products |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4057672A (en) | 1973-05-29 | 1977-11-08 | The Goodyear Tire & Rubber Company | Compounded polyvinyl chloride |
| IE39517B1 (en) * | 1973-06-27 | 1978-10-25 | Bioresearch Sas | Double salts of s-adenosyl-l-methhionine |
| US4432975A (en) * | 1981-04-13 | 1984-02-21 | Icn Pharmaceuticals, Inc. | Process for introducing vitamin B-12 into the bloodstream |
| IT1137640B (it) | 1981-08-24 | 1986-09-10 | Bioresearch Srl | Sali stabili della s-adenosilmetionina,processo per la loro preparazione e composizioni terapeutiche che li comprendono come principio attivo |
| JP2000508649A (ja) * | 1996-04-16 | 2000-07-11 | ノバルティス・コンシューマー・ヘルス・ソシエテ・アノニム | 速崩解性経口剤形物 |
| EP1802276A1 (en) * | 2004-10-15 | 2007-07-04 | Pfizer Products Inc. | Compositions and methods for intranasal, buccal, sublingual and pulmonary delivery of varenicline |
| US20060127506A1 (en) * | 2004-12-10 | 2006-06-15 | Hebert Rolland F | Compositions of S-adenosyl-L-methionine |
| US20060198885A1 (en) * | 2005-02-22 | 2006-09-07 | Sun Pharmaceutical Industries Ltd. | Oral pharmaceutical composition |
| ITRM20050344A1 (it) * | 2005-06-30 | 2007-01-01 | Luca Maria De | Sali o complessi di sostanze metil-donatrici con acido fitico o suoi derivati e relativo metodo di sintesi. |
| ITMI20060026A1 (it) * | 2006-01-10 | 2007-07-11 | Truffini & Regge Farmaceutici Srl | Composizioni per uso rale a base di s-adenosilmetionina e processo per il loro ottenimento |
| RU2313349C2 (ru) * | 2006-01-16 | 2007-12-27 | Михаил Аркадьевич Шурдов | Способ лечения онкологических заболеваний |
| ITMI20060629A1 (it) * | 2006-03-31 | 2007-10-01 | Daniele Giovannone | Composizioni solide orali a base di s-adenosilmetionina e processo per il loro ottenimento |
| US8597640B2 (en) * | 2007-10-31 | 2013-12-03 | University Of Massachusetts Lowell | Over-the-counter vitamin/nutriceutical formulation that provides neuroprotection and maintains or improves cognitive performance in alzheimer's disease and normal aging |
| EP2189154A1 (en) * | 2008-11-25 | 2010-05-26 | Gnosis S.p.A. | Effervescent tablets and mouth-soluble granulates of S-adenosyl methionine and process for the preparation thereof |
| EP2193787A1 (en) * | 2008-12-02 | 2010-06-09 | Giorgio Stramentinoli | Formulations for systemic buccal delivery comprising s-adenosylmethionine, their preparation and use |
-
2009
- 2009-02-09 IT ITMI2009A000162A patent/IT1393331B1/it active
-
2010
- 2010-01-11 PT PT107033557T patent/PT2393475E/pt unknown
- 2010-01-11 BR BRPI1008213A patent/BRPI1008213A2/pt not_active Application Discontinuation
- 2010-01-11 ES ES10703355.7T patent/ES2539310T3/es active Active
- 2010-01-11 US US13/147,883 patent/US10149821B2/en active Active
- 2010-01-11 AU AU2010212042A patent/AU2010212042A1/en not_active Abandoned
- 2010-01-11 RU RU2011137151/15A patent/RU2524645C2/ru active
- 2010-01-11 DK DK10703355.7T patent/DK2393475T3/en active
- 2010-01-11 PL PL10703355T patent/PL2393475T3/pl unknown
- 2010-01-11 WO PCT/IB2010/050087 patent/WO2010089674A1/en active Application Filing
- 2010-01-11 EP EP10703355.7A patent/EP2393475B1/en active Active
- 2010-01-11 CA CA2752009A patent/CA2752009C/en active Active
-
2011
- 2011-06-28 IL IL213817A patent/IL213817A0/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| PL2393475T3 (pl) | 2015-08-31 |
| RU2011137151A (ru) | 2013-03-20 |
| EP2393475B1 (en) | 2015-03-11 |
| RU2524645C2 (ru) | 2014-07-27 |
| US10149821B2 (en) | 2018-12-11 |
| AU2010212042A1 (en) | 2011-07-21 |
| DK2393475T3 (en) | 2015-06-15 |
| US20110300081A1 (en) | 2011-12-08 |
| IT1393331B1 (it) | 2012-04-20 |
| EP2393475A1 (en) | 2011-12-14 |
| IL213817A0 (en) | 2011-07-31 |
| ES2539310T3 (es) | 2015-06-29 |
| PT2393475E (pt) | 2015-07-17 |
| CA2752009A1 (en) | 2010-08-12 |
| AU2010212042A2 (en) | 2011-08-18 |
| WO2010089674A1 (en) | 2010-08-12 |
| ITMI20090162A1 (it) | 2010-08-10 |
| CA2752009C (en) | 2016-09-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BRPI1008213A2 (pt) | composições efervecentes e/ou solúveis por via oral contendo pelo menos um sal de s-adenosil metionina(same) | |
| FI2068839T4 (fi) | Nilotinibia tai sen suolaa käsittäviä farmaseuttisia koostumuksia | |
| HUE047955T2 (hu) | S-adenozil metioninsó alapú szilárd orális készítmények és eljárás azok elõállítására | |
| HK1142001A1 (en) | Preparation for transnasal application | |
| DK2068822T3 (da) | Selvpræserverede vandige farmaceutiske sammensætninger | |
| BRPI0811110A2 (pt) | Formulação de nicotina oral tamponada com aminoácido | |
| IL194546A0 (en) | Arylaminopyridine derivatives and pharmaceutical compositions containing them | |
| EP2057987A4 (en) | PHARMACEUTICAL COMPOSITION CONTAINING AN ENCAPSULATED STATINE NANOPARTICLE | |
| IL185866A0 (en) | Oral dosage forms of gemcitabine derivatives | |
| BRPI0809661A2 (pt) | Composição farmacêutica estabilizada contendo pregabalina | |
| ZA200901702B (en) | Self-preserved aqueous pharmaceutical compositions | |
| EP2193795A4 (en) | AQUEOUS PHARMACEUTICAL COMPOSITION CONTAINING LATANOPROST | |
| IS2385B (is) | Klópidógrel bísúlfat lyfjasamsetningar | |
| BRPI0821455A2 (pt) | Composições farmacêuticas de amlopidina e valsartan | |
| IL208325A0 (en) | Stabilizing lipis compositions for oral pharmaceutical agents | |
| ZA200810162B (en) | Phenylphrine pulsed release formulations and pharmaceutical compositions | |
| IL192454A0 (en) | Oral s-adenosylmethionine compositions | |
| DK1985303T3 (da) | Oral sammensætning indeholdende interferon-alpha | |
| BRPI1008356A2 (pt) | "sal de adição ácido de udenafil, respectivo método de preparação e composição farmacêutica" | |
| ZA200901164B (en) | Self preserved aqueous pharmaceutical compositions | |
| EP2086524A4 (en) | TRANSNASAL ANTICONVULSIVE PHARMACEUTICAL COMPOSITION | |
| IL193115A0 (en) | Sulfonamide derivatives, their preparation and pharmaceutical compositions containing them | |
| IL201912A0 (en) | Aqueous pharmaceutical composition | |
| ITMI20062230A1 (it) | Composto 2-alchil-indazolico procedimento per preparalo e composizione farmaceutica che lo comprende | |
| ZA200901001B (en) | Antiretroviral solid oral composition |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
| B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] | ||
| B06T | Formal requirements before examination [chapter 6.20 patent gazette] | ||
| B11E | Dismissal acc. art. 34 of ipl - requirements for examination incomplete | ||
| B11T | Dismissal of application maintained [chapter 11.20 patent gazette] |